Matches in Nanopublications for { ?s ?p "[The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_assertion description "[The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565937.RAgD7oJNB6_9iI2w2XK_2w3fpGzSg7agmLC6P1wUafbTc130_provenance.
- NP394893.RAdO9-qgv9JwmeXIdbiIn7kRwGG48oxd1Rma1f-4NYHCY130_assertion description "[The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394893.RAdO9-qgv9JwmeXIdbiIn7kRwGG48oxd1Rma1f-4NYHCY130_provenance.
- NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_assertion description "[The use of FASN inhibitors has been limited until now by anorexia and weight loss, which is associated with the stimulation of fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718255.RAoeTQkDL1nT9AN1Ef6wz83UX3330PNWD5CUsdoDtrufs130_provenance.